Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Features of Adult Patients with Isolated Pulmonary Valve Endocarditis: A Systematic Review.

Microorganisms·2026
Same author

Reinterpreting I<sup>2</sup> Thresholds: Toward Context-Specific Heterogeneity Assessment in Evidence Synthesis.

Cochrane evidence synthesis and methods·2026
Same author

69-Year-Old Woman With Generalized Weakness, Diarrhea, and Weight Loss.

Mayo Clinic proceedings·2026
Same author

Systemic Embolic Events in People Who Inject Drugs With Patent Foramen Ovale and Right-Sided Infective Endocarditis: A Systematic Review.

Open forum infectious diseases·2026
Same author

Liver support systems for adults with acute liver failure.

The Cochrane database of systematic reviews·2026
Same author

Lead Extraction and Outcomes in Frail Patients With Cardiac Implantable Electronic Device Infections in the United States.

Journal of cardiovascular electrophysiology·2026
Same journal

<i>Pneumocystis</i> pneumonia in non-HIV immunocompromised patients in 2026: evolving therapeutic standards.

Expert review of anti-infective therapy·2026
Same journal

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Expert review of anti-infective therapy·2026
Same journal

Synergistic antifungal effects and potential mode of action of crisaborole combined with azoles against drug-resistant <i>Candida albicans</i>.

Expert review of anti-infective therapy·2026
Same journal

Anti-infective therapy and novel treatment options for coccidioidomycosis.

Expert review of anti-infective therapy·2026
Same journal

Intensivists' practices and perceptions regarding β-lactam prescribing and monitoring in intensive care units: a cross-sectional survey.

Expert review of anti-infective therapy·2026
Same journal

How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts.

Expert review of anti-infective therapy·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

The endocarditis team: a review.

Aoife Maher1,2,3, Larry M Baddour4, Sami El Dalati5

  • 1Department of Cardiology, Mater Private Hospital, Dublin, Ireland.

Expert Review of Anti-Infective Therapy
|June 25, 2026
PubMed
Summary
This summary is machine-generated.

Establishing an endocarditis team (ET) significantly reduces mortality and improves diagnosis for infective endocarditis (IE) patients. This multidisciplinary approach enhances patient outcomes in complex IE cases.

Keywords:
Cardiac surgeryendocarditis teaminfective endocarditismortalitymultidisciplinary careoutcomes

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Related Experiment Videos

Last Updated: Jun 26, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Healthcare Management

Background:

  • Infective endocarditis (IE) presents diagnostic and management challenges, leading to high morbidity and mortality.
  • The 2015 European Society of Cardiology (ESC) guidelines recommend establishing an endocarditis team (ET) for IE management.
  • Evidence supporting the efficacy of ETs in improving patient care is crucial.

Purpose of the Study:

  • To evaluate the evidence supporting the implementation of endocarditis teams (ETs) in managing infective endocarditis (IE).
  • To assess the impact of ETs on patient outcomes and quality of care for IE.

Main Methods:

  • A systematic review of nineteen before-and-after observational studies was conducted.
  • The studies included a total of 5,327 patients (3,069 before ET, 2,258 after ET).
  • No randomized controlled trials (RCTs) were identified.

Main Results:

  • Implementation of ETs was associated with a significant reduction in in-hospital mortality (20.9% to 16.3%).
  • The proportion of IE cases with unidentified organisms decreased significantly after ET introduction (23.8% to 9.8%).
  • Consistent observational evidence supports the effectiveness of ETs.

Conclusions:

  • Endocarditis teams (ETs) are effective in reducing mortality and improving diagnostic accuracy in infective endocarditis (IE) patients.
  • Despite limitations in study design, the consistent findings support widespread ET implementation.
  • Multidisciplinary models like ETs are biologically plausible and align with successful approaches in other complex diseases.